VentureMed Group Transforms into Flex Vascular to Emphasize Vascular Innovation

VentureMed Group Transitions to Flex Vascular

In an exciting development in the medical device industry, VentureMed Group, Inc. has officially announced that it will be operating under the name Flex Vascular. This change highlights the company’s ongoing dedication to vascular innovations, particularly in the realm of access management for arteriovenous (AV) fistulas and grafts, as well as for patients with peripheral vascular disease.

Denis Harrington, the CEO of the company, emphasized the significance of this branding update, stating, "Flex Vascular more clearly represents who we are and what we do." This shift aims to sync the company’s public image with its core focus on vascular solutions and the groundbreaking technology they offer to both clinicians and patients.

Alongside this name change, it's essential to note that VentureMed Group, Inc. will remain the official legal entity. The rebranding to Flex Vascular reflects a strategic move to enhance visibility and alignment with the company's flagship product — the FLEX Vessel Prep™ System. This innovative device is recognized for its role in optimizing vessel preparation through a unique technology known as Kinetic Endovascular Micro-incision Creation (KEMIC).

Unlike conventional balloon-based methods, which exert static pressure on the vessels, the KEMIC technology introduces controlled motion. This advanced technique enables the creation of precise and long micro-incisions, potentially resulting in a variety of benefits. These advantages include enhanced drug uptake when used in combination with therapeutic agents and a reduction in trauma to blood vessels, thereby lowering the risk of restenosis — the re-narrowing of blood vessels after they have been treated.

As the company navigates this transition, stakeholders such as customers and partners will begin to see the Flex Vascular branding reflected across various channels, including communication materials and online platforms. However, existing contracts, pricing structures, product availability, and customer support will remain unaffected by this change.

Flex Vascular is headquartered in Minnesota, where it continues to pioneer advancements in endovascular solutions tailored for AV access and peripheral vascular interventions. The FLEX Vessel Prep™ System sustains its status as an FDA 510(k)-cleared and CE Mark-approved product, indicative of its effectiveness and safety in medical applications.

This rebranding marks an important chapter for the company, aligning its market identity with its innovative technology. Interested parties are encouraged to stay updated by visiting the newly established website at www.FlexVascular.com.

In summary, Flex Vascular represents not just a name change, but a reaffirmation of the company’s commitment to leading in vascular solutions and improving patient outcomes through cutting-edge technology. The future looks promising as the company integrates its new identity with its existing strengths in the healthcare landscape.

For further inquiries, media representatives can reach out to Tom Michals at [email protected] or contact him at +1(763) 951-0280.